Share
1,655 Posts.
lightbulb Created with Sketch. 510
clock Created with Sketch. 12/04/23
18:06
Share
Originally posted by CM662:
↑
Hi Jamwolf, I agree the CEO would be much better placed out with customers. However as he has decided not to lease his nice new office in Melbourne then I would rather he did something valuable to earn his dollar rather that continue to do nothing, talk to no one and avoid legitimate questions with inane answers written by a third party. It was his ASX announced "initiative" to set up the forum to communicate with investors. If he does not like the questions or is so naive to not see the obvious ones that would come then thats on him. If the CEO and his leadership knew their market they would have this data at their fingertips already as its a fundimental data point in the US for all device companies making products for pharma products they dont own. If a patient gets branded inhalers in hopsital and then goes to CVS/Walgreens and the community pharmacy swops out to a generic that is not compatible with the sensor, what happens ? The data flow and value is gone. The majority of asthmatics are managed in the community, its the biggest market and opportunity. If ADR are blind to generics then thats a worry. They should at least have assessed that issue, have the answer and be able to address the question rather than dodge it.
Expand
CM, I see ADR has got back to you today in relation to answering your questions in person. They are looking at actively engaging with their investors and are offering to do it in person at a sooner date then the AGM. This is great news Imo as it not only shows good leadership but it also shows they are listening. Well done ADR
